Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.060
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
1.040
-0.020 (-1.88%)
After-hours: Dec 5, 2025, 6:19 PM EST

Aprea Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-13.04-12.96-14.29-112.66-37.13-53.48
Depreciation & Amortization
0.020.020.010.190.270.23
Asset Writedown & Restructuring Costs
---72.52--
Stock-Based Compensation
0.510.510.4416.987.814.98
Other Operating Activities
0.03-0.070.04-0.28-0.320.89
Change in Accounts Payable
-0.51-0.310.83-0.86-2.732.33
Change in Unearned Revenue
--0.530.53---
Change in Other Net Operating Assets
-0.46-0.210.26-0.9-5.63.25
Operating Cash Flow
-13.44-13.56-12.18-25.01-37.69-41.8
Capital Expenditures
--0.02-0.09---0.03
Investing Cash Flow
--0.02-0.09---0.03
Issuance of Common Stock
0.9816.145.790.681.750.15
Other Financing Activities
-0.04-1.32-0.65---
Financing Cash Flow
0.9314.825.140.681.750.15
Foreign Exchange Rate Adjustments
-0.02-0.01-0.010.04-00.61
Net Cash Flow
-12.531.24-7.14-24.29-35.94-41.07
Free Cash Flow
-13.44-13.57-12.27-25.01-37.69-41.83
Free Cash Flow Margin
-2753.58%-903.26%-2103.92%---
Free Cash Flow Per Share
-2.20-2.46-3.39-15.09-35.41-39.59
Levered Free Cash Flow
-9.07-9.29-7.67-7.97--
Unlevered Free Cash Flow
-9.07-9.29-7.67-7.97--
Change in Working Capital
-0.97-1.061.62-1.76-8.335.57
Source: S&P Capital IQ. Standard template. Financial Sources.